- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 3 residues within 4Å:- Chain A: G.2, G.105, P.106
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: R.7, F.9, D.30, D.31
Ligand excluded by PLIPEDO.7: 9 residues within 4Å:- Chain A: A.1, H.4, L.180, Q.181, R.182, Y.210, P.211, E.265
- Ligands: TRS.15
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: P.48, E.54, W.61
Ligand excluded by PLIPEDO.9: 2 residues within 4Å:- Chain A: G.2, P.106
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: D.197, H.198
- Ligands: ZN.2
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: Q.33, R.49
- Ligands: EDO.21
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: Y.86, Y.119, D.120, R.122, D.138
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain A: M.6, Y.8, Q.64, R.67, Y.160, E.164, S.168, Y.172
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: R.36, E.47, P.48, R.49
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: F.9, M.99, Q.116
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain A: V.13, S.93
- Chain B: P.33, S.34, D.35
Ligand excluded by PLIPEDO.20: 3 residues within 4Å:- Chain A: R.22
- Chain B: S.34, D.35
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain A: R.49, G.238
- Chain B: S.53, L.66, Y.68
- Ligands: EDO.11, EDO.23
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain B: Q.9, V.10, K.95, W.96, D.97
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain A: P.236
- Chain B: S.53, Y.64
- Ligands: EDO.21
Ligand excluded by PLIP- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 1 x EKG: (2R)-2,3-dihydroxypropyl hexadecanoate(Non-covalent)
EKG.16: 15 residues within 4Å:- Chain A: Y.8, S.10, F.23, V.25, R.67, V.68, A.71, F.75, T.98, M.99, S.100, Y.115, Q.156, W.157, Y.160
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:Y.8, A:Y.8, A:F.23, A:V.25, A:V.68, A:A.71, A:F.75, A:F.75, A:Y.115
- Water bridges: A:W.157
- Salt bridges: A:R.67
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shima, Y. et al., Crystal structures of lysophospholipid-bound MHC class I molecules. J.Biol.Chem. (2020)
- Release Date
- 2020-04-29
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 1 x EKG: (2R)-2,3-dihydroxypropyl hexadecanoate(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shima, Y. et al., Crystal structures of lysophospholipid-bound MHC class I molecules. J.Biol.Chem. (2020)
- Release Date
- 2020-04-29
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D